St. Jude Medical, Inc. 

(Public, NYSE:STJ)   Watch this stock   
Find more results for STJ
Dec 1, 2009
Piper Jaffray Healthcare Conference - 10:00AM EST - Add to calendar
Nov 12, 2009
Credit Suisse Healthcare Conference
Oct 21, 2009
Q3 2009 Earnings Release
Oct 21, 2009
Q3 2009 Earnings Conference Call - Webcast
Sep 15, 2009
Morgan Stanley Global Healthcare Conference - Webcast
Sep 10, 2009
Thomas Weisel Partners Healthcare Conference
More events from AOL Finance »    

Key stats and ratios

Q4 (Oct '09) 2009
Net profit margin 14.40% 8.81%
Operating margin 20.87% 15.01%
EBITD margin - 19.27%
Return on average assets 10.12% 6.95%
Return on average equity 18.18% 12.47%
Employees 14,000 -

Address

One Lillehei Plaza
St. Paul, MN 55117
United States - Map
+1-651-4832000 (Phone)
+1-651-4828318 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

St. Jude Medical, Inc. discussed on blogs

Ranking 300+ Large Cap Stocks by Cash Flow per Share - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - 17 hours ago
Ranking Healthcare Stocks by Upside Potential - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 19, 2009

St. Jude Medical, Inc. discussions

  View all discussions »

Description

St. Jude Medical, Inc. (St. Jude)develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiology and cardiac surgery and atrial fibrillation therapy areas and implantable neurostimulation devices for the management of chronic pain. The Company operates in four business segments: Cardiac Rhythm Management (CRM), Cardiovascular (CV), Atrial Fibrillation (AF) and Neuromodulation Systems (Neuro). On July 3, 2008, the Company completed the acquisition of EP MedSystems, Inc. On December 19, 2008, St. Jude acquired Radi Medical Systems. On December 22, 2008, St. Jude acquired MediGuide Inc.

Officers and directors

Daniel J. Starks
Chairman of the Board, President, Chief Executive Officer
Age: 54
Bio & Compensation - Reuters
John C. Heinmiller
Chief Financial Officer, Executive Vice President
Age: 54
Bio & Compensation - Reuters
Michael T. Rousseau
Group President
Age: 53
Bio & Compensation - Reuters
Jane J. Song
President - Atrial Fibrillation Division
Age: 46
Bio & Compensation - Reuters
Christopher G. Chavez
President - Neuromodulation
Age: 53
Bio & Compensation - Reuters
Frank J. Callaghan
President - Cardivasular Division
Age: 55
Bio & Compensation - Reuters
Denis M. Gestin
President - International
Age: 45
Bio & Compensation - Reuters
Eric S. Fain M.D.
President - Cardiac Rhythm Management Division
Age: 48
Bio & Compensation - Reuters
Thomas R. Northenscold
Vice President - Information Technology, Chief Information Officer
Age: 51
Bio & Compensation - Reuters
Pamela S. Krop
Vice President, General Counsel, Corporate Secretary
Age: 50
Bio & Compensation - Reuters